Correlation Between Issuer Direct and Kiniksa Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Issuer Direct and Kiniksa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Issuer Direct and Kiniksa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Issuer Direct Corp and Kiniksa Pharmaceuticals, you can compare the effects of market volatilities on Issuer Direct and Kiniksa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Issuer Direct with a short position of Kiniksa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Issuer Direct and Kiniksa Pharmaceuticals.
Diversification Opportunities for Issuer Direct and Kiniksa Pharmaceuticals
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Issuer and Kiniksa is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Issuer Direct Corp and Kiniksa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kiniksa Pharmaceuticals and Issuer Direct is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Issuer Direct Corp are associated (or correlated) with Kiniksa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kiniksa Pharmaceuticals has no effect on the direction of Issuer Direct i.e., Issuer Direct and Kiniksa Pharmaceuticals go up and down completely randomly.
Pair Corralation between Issuer Direct and Kiniksa Pharmaceuticals
Given the investment horizon of 90 days Issuer Direct Corp is expected to generate 0.48 times more return on investment than Kiniksa Pharmaceuticals. However, Issuer Direct Corp is 2.1 times less risky than Kiniksa Pharmaceuticals. It trades about -0.11 of its potential returns per unit of risk. Kiniksa Pharmaceuticals is currently generating about -0.26 per unit of risk. If you would invest 1,020 in Issuer Direct Corp on August 28, 2024 and sell it today you would lose (47.00) from holding Issuer Direct Corp or give up 4.61% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Issuer Direct Corp vs. Kiniksa Pharmaceuticals
Performance |
| Timeline |
| Issuer Direct Corp |
| Kiniksa Pharmaceuticals |
Issuer Direct and Kiniksa Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Issuer Direct and Kiniksa Pharmaceuticals
The main advantage of trading using opposite Issuer Direct and Kiniksa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Issuer Direct position performs unexpectedly, Kiniksa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kiniksa Pharmaceuticals will offset losses from the drop in Kiniksa Pharmaceuticals' long position.| Issuer Direct vs. eGain | Issuer Direct vs. Research Solutions | Issuer Direct vs. Meridianlink | Issuer Direct vs. CoreCard Corp |
| Kiniksa Pharmaceuticals vs. Nuvalent | Kiniksa Pharmaceuticals vs. Ventyx Biosciences | Kiniksa Pharmaceuticals vs. Arcellx | Kiniksa Pharmaceuticals vs. Cullinan Oncology LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |